Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
NVIDIA
NVDA
|
$307M |
| 2 |
Mercado Libre
MELI
|
$289M |
| 3 |
Atlassian
TEAM
|
$283M |
| 4 |
Shopify
SHOP
|
$275M |
| 5 |
Roblox
RBLX
|
$243M |
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
$1.38B |
| 2 |
Meta Platforms (Facebook)
META
|
$565M |
| 3 |
Illumina
ILMN
|
$460M |
| 4 |
Ferrari
RACE
|
$328M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
$296M |
Sector Composition
| 1 | Healthcare | 27.94% |
| 2 | Consumer Discretionary | 24.47% |
| 3 | Technology | 18.46% |
| 4 | Communication Services | 10.28% |
| 5 | Financials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Consolidated Edison
ED
$35.4B
| $26.3M | 0.03% |
276,383
-149,784
| -35% | -$14.3M |
|
|
EXAI
177
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $26.2M | 0.03% |
4,918,295
+39,359
| +0.8% | +$210K |
|
178
Twist Bioscience
TWST
$1.55B
| $25.8M | 0.03% |
1,085,579
+194,611
| +22% | +$4.63M |
|
179
Joby Aviation
JOBY
$11.5B
| $25.7M | 0.03% |
7,686,144
+449
| +0% | +$1.5K |
|
|
ADAP
180
Adaptimmune Therapeutics
ADAP
$10.9M
| $25.1M | 0.03% |
17,169,939
+2,505,003
| +17% | +$3.66M |
|
181
Eversource Energy
ES
$23.6B
| $24.6M | 0.03% |
294,010
-103,305
| -26% | -$8.66M |
|
182
KE Holdings
BEKE
$22.4B
| $24.1M | 0.03% |
1,724,541
+22,435
| +1% | +$313K |
|
|
LILM
183
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
| $21.5M | 0.02% |
18,828,577
| – | – |
|
|
EVBG
184
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $20.7M | 0.02% |
699,666
+24,129
| +4% | +$714K |
|
185
Hershey
HSY
$37.6B
| $20.6M | 0.02% |
88,918
-6,059
| -6% | -$1.4M |
|
186
EverQuote
EVER
$860M
| $20.1M | 0.02% |
1,362,022
+31,957
| +2% | +$471K |
|
|
MEKA
187
DELISTED
MELI Kaszek Pioneer Corp Class A Ordinary Shares
MEKA
| $19.9M | 0.02% |
2,000,000
| – | – |
|
188
Remitly
RELY
$4.02B
| $19.9M | 0.02% |
+1,738,334
| New | +$19.9M |
|
189
Aurora
AUR
$10.6B
| $18.1M | 0.02% |
14,996,845
| – | – |
|
190
Waters Corp
WAT
$18.2B
| $18M | 0.02% |
52,443
-23,941
| -31% | -$8.2M |
|
191
Beam Therapeutics
BEAM
$2.11B
| $17.8M | 0.02% |
454,828
+69,610
| +18% | +$2.72M |
|
192
Veeco
VECO
$1.47B
| $17.8M | 0.02% |
957,191
+89,852
| +10% | +$1.67M |
|
193
Archer Daniels Midland
ADM
$30.2B
| $17.8M | 0.02% |
191,454
-5,381
| -3% | -$500K |
|
194
Peloton Interactive
PTON
$3.27B
| $15.9M | 0.02% |
2,006,022
-23,113,119
| -92% | -$184M |
|
195
Transmedics
TMDX
$3.55B
| $15.6M | 0.02% |
253,319
+218,048
| +618% | +$13.5M |
|
196
Charles River Laboratories
CRL
$8.07B
| $15.6M | 0.02% |
71,372
-527
| -0.7% | -$115K |
|
197
Digimarc
DMRC
$181M
| $15.2M | 0.02% |
820,539
+39,902
| +5% | +$738K |
|
198
Sutro Biopharma
STRO
$89.9M
| $15.1M | 0.02% |
1,868,615
| – | – |
|
199
Q2 Holdings
QTWO
$4.92B
| $14.6M | 0.02% |
542,498
-59,088
| -10% | -$1.59M |
|
200
Masimo
MASI
$8B
| $14.2M | 0.01% |
96,135
+2,501
| +3% | +$370K |
|